Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
13.75
+0.28 (2.08%)
At close: Oct 8, 2025, 4:00 PM EDT
13.87
+0.12 (0.87%)
Pre-market: Oct 9, 2025, 8:00 AM EDT
Avantor Market Cap
Avantor has a market cap or net worth of $9.37 billion as of October 9, 2025. Its market cap has decreased by -48.12% in one year.
Market Cap
9.37B
Enterprise Value
13.17B
1-Year Change
-48.12%
Ranking
Category
Stock Price
$13.75
Market Cap Chart
Since May 17, 2019, Avantor's market cap has increased from $4.93B to $9.37B, an increase of 90.24%. That is a compound annual growth rate of 10.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 9.37B | -34.63% |
| Dec 31, 2024 | 14.34B | -7.13% |
| Dec 29, 2023 | 15.44B | 8.60% |
| Dec 30, 2022 | 14.22B | -44.64% |
| Dec 31, 2021 | 25.68B | 57.75% |
| Dec 31, 2020 | 16.28B | 56.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |